Showing 481 - 500 results of 4,319 for search '"Psychosis"', query time: 0.10s Refine Results
  1. 481

    Deliberate self-harm in a patient with hyperthyroidism with acute psychosis by Haw Huo Wong, Pang, Nicholas Tze Ping

    Published 2021
    “…After supplemental thyroxine was stopped and olanzapine was started, she achieved biochemical euthyroid followed by remission of psychosis within 1 week. This case illustrates the importance of elucidating organic causes of psychosis as they are easily and swiftly reversible.…”
    Get full text
    Get full text
    Article
  2. 482

    Maintenance Electroconvulsive Therapy Augmentation on Clozapine-Resistant Psychosis with Neurosyphilis by Othman, Zahiruddin, Nordin, Muhammad Farhan

    Published 2018
    “…Conclusion: Maintenance electroconvulsive therapy augmentation on clozapine-resistant psychosis with neurosyphilis is effective and safe but has never been reported in the literature to the authors' knowledge. …”
    Get full text
    Article
  3. 483

    Protocol for the Psychosis Immune Mechanism Stratified Medicine (PIMS) trial: a randomised double-blind placebo-controlled trial of single-dose tocilizumab in patients with psychosis by Stephen Burgess, Peter Jones, Rachel Upthegrove, Carmine Pariante, Graham K Murray, Anthony David, Martin Wilson, Nicholas Barnes, Paola Dazzan, John Suckling, Valeria Mondelli, Muzaffer Kaser, Neil Harrison, Georgios Gkoutos, Golam M Khandaker, Deepak Jadon, James MacCabe, Gary Donohoe, Alice Egerton, Bill Deakin, Jack Rogers, Éimear M Foley, Sian Lowri Griffiths, Alexander Murray, Fabiana Corsi-Zuelli, Hannah Hickinbotham, Ella Warwick, Nicholas M Barnes, Golam Khandaker, David Cotter, Ed Bullmore, Eva Meisenzahl, Joanna Neill, Nikos Koutsouleris, Stephen Wood

    Published 2023-03-01
    “…Introduction Evidence suggests a potentially causal role of interleukin 6 (IL-6), a pleiotropic cytokine that generally promotes inflammation, in the pathogenesis of psychosis. However, no interventional studies in patients with psychosis, stratified using inflammatory markers, have been conducted to assess the therapeutic potential of targeting IL-6 in psychosis and to elucidate potential mechanism of effect. …”
    Get full text
    Article
  4. 484
  5. 485
  6. 486
  7. 487
  8. 488
  9. 489
  10. 490
  11. 491

    Evaluation of Vitamin D in the serum of in-hospital patients with psychosis. Retrospective study. by E. Kapiris, E. Laskos

    Published 2023-03-01
    “…Belvederi Murri M, Respino M, Masotti M, et al. Vitamin D and psychosis: mini meta-analysis. Schizophr Res. 2013;150(1):235-239. doi:10.1016/j.schres.2013.07.017 2. …”
    Get full text
    Article
  12. 492
  13. 493
  14. 494
  15. 495

    Association between cannabis use and symptoms of psychosis: a mega-analysis by M. Argote, B. Rolland, G. Sescousse, J. Brunelin, E. Fakra, M. Nourredine, R. Jardri

    Published 2023-03-01
    “…Regular cannabis use (RCU) was found associated with the severity of positive symptoms of psychosis i.e., delusion or hallucinations. However, the association with negative symptoms, i.e. blunted affect or social withdrawal, is less straightforward. …”
    Get full text
    Article
  16. 496
  17. 497
  18. 498
  19. 499

    Predictors of transition in patients with clinical high risk for psychosis: an umbrella review by Christina Andreou, Sofia Eickhoff, Marco Heide, Renate de Bock, Jonas Obleser, Stefan Borgwardt

    Published 2023-08-01
    “…We aimed to summarize evidence from systematic reviews and meta-analyses on predictors of transition to psychosis in CHR patients, among characteristics and biomarkers assessed at baseline. …”
    Get full text
    Article
  20. 500